ARTICLE | Company News
Crucell, Pepscan Therapeutics deal
March 14, 2011 7:00 AM UTC
Crucell will use Pepscan's Chemical Linkage of Peptides onto Scaffolds (CLIPS) technology to develop vaccines to treat undisclosed infectious diseases. CLIPS technology presents one or more linear pep...